David A Cameron
Overview
Explore the profile of David A Cameron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
5650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunn J, Donnelly P, Elbeltagi N, Marshall A, Hopkins A, Thompson A, et al.
Lancet
. 2025 Feb;
405(10476):396-407.
PMID: 39892911
Background: The frequency of mammographic surveillance for women after diagnosis of breast cancer varies globally. The aim of this study was to evaluate whether less than annual mammography was non-inferior...
2.
Ignatiadis M, Bailey A, McArthur H, El-Abed S, de Azambuja E, Metzger O, et al.
JAMA
. 2025 Jan;
PMID: 39883436
Importance: Triple-negative breast cancer is an aggressive subtype with a high incidence in young patients, a high incidence in non-Hispanic Black women, and a high risk of progression to metastatic...
3.
Guest D, Cameron D, Schwarz D, Leong U, Richards V, Carney L
J Acoust Soc Am
. 2024 Dec;
156(6):4303-4325.
PMID: 39740047
Profile-analysis experiments measure the ability to discriminate complex sounds based on patterns, or profiles, in their amplitude spectra. Studies of profile analysis have focused on normal-hearing listeners and target frequencies...
4.
Karlsson P, Fyles A, Chang S, Arrick B, Baehner F, Malmstrom P, et al.
J Natl Cancer Inst
. 2024 Oct;
117(3):486-495.
PMID: 39423142
Background: There are currently no molecular tests to identify individual breast cancers where radiotherapy (RT) offers no benefit. Profile for the Omission of Local Adjuvant Radiotherapy (POLAR) is a 16-gene...
5.
Purdie C, Clark G, Cameron D, Petty R, Mariappan P, Graham J, et al.
J Cancer Policy
. 2024 Sep;
42:100502.
PMID: 39243812
Introduction: The COVID-19 pandemic disrupted normal pathways to cancer diagnosis, particularly for screening and non-acute symptomatic patients. While reductions in overall cancer diagnoses have been reported elsewhere, any differential effects...
6.
Williams L, Kunkler I, Taylor K, Dunlop J, Piper T, Caldwell J, et al.
Lancet Oncol
. 2024 Aug;
25(9):1213-1221.
PMID: 39127062
Background: Breast-conserving surgery, adjuvant systemic therapy, and radiotherapy are the standard of care for most women with early breast cancer. There are few reports of clinical outcomes beyond the first...
7.
Coles C, Earl H, Anderson B, Barrios C, Bienz M, Bliss J, et al.
Lancet
. 2024 Apr;
403(10439):1895-1950.
PMID: 38636533
No abstract available.
8.
Prat A, Solovieff N, Andre F, OShaughnessy J, Cameron D, Janni W, et al.
Clin Cancer Res
. 2023 Nov;
30(4):793-802.
PMID: 37939142
Purpose: The MONALEESA-2, -3, -7 trials demonstrated statistically significant and clinically meaningful progression-free survival and overall survival (OS) benefits with ribociclib plus endocrine therapy (ET) versus ET alone in hormone...
9.
Joharatnam-Hogan N, Hatem D, Cafferty F, Petrucci G, Cameron D, Ring A, et al.
Br J Cancer
. 2023 Jul;
129(4):706-720.
PMID: 37420000
Background: Pre-clinical models demonstrate that platelet activation is involved in the spread of malignancy. Ongoing clinical trials are assessing whether aspirin, which inhibits platelet activation, can prevent or delay metastases....
10.
Carney L, Cameron D, Kinast K, Feld C, Schwarz D, Leong U, et al.
Hear Res
. 2023 May;
435:108788.
PMID: 37224720
This study concerns the effect of hearing loss on discrimination of formant frequencies in vowels. In the response of the healthy ear to a harmonic sound, auditory-nerve (AN) rate functions...